The TXNRD2 mutation in this family and the other recently described FGD syndromes due to mutations in NNT and MCM4 highlight important pathogenic pathways in addition to defective ACTH signaling, causing glucocorticoid deficiency. This evidence concerns the gene TXNRD2 and familial glucocorticoid deficiency.